NCT00046943View on ClinicalTrials.gov

Atrasentan in Treating Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2007

Conditions
Prostate Cancer
Interventions
DRUG

atrasentan hydrochloride

Trial Locations (1)

90095-1738

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY